XML 77 R62.htm IDEA: XBRL DOCUMENT v3.22.2.2
Share-Based Compensation - Summary of SARs Outstanding (Detail)
$ / shares in Units, shares in Thousands, $ in Millions
12 Months Ended
Sep. 30, 2022
USD ($)
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]  
SARs, beginning balance (shares) 6,295
SARs, granted (shares) 909
SARs, exercised (shares) (1,408)
SARs, forfeited, canceled or expired (shares) (191)
Embecta spin-off adjustment (shares) (159)
Adjustments to BD awards related to the spin-off of Embecta (shares) 97
SARs, ending balance (shares) 5,544
SARs, Vested and expected to vest at ending balance (shares) 5,377
SARs, Exercisable at ending balance (shares) 3,877
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]  
SARs, weighted average exercise price, beginning balance (USD per share) | $ / shares $ 179.64
SARs, weighted average exercise price, granted (USD per share) | $ / shares 245.09
SARs, weighted average exercise price, exercised (USD per share) | $ / shares 125.57
SARs, weighted average exercise price, forfeited, canceled or expired (USD per share) | $ / shares 234.50
Embecta spin-off adjustment (USD per share) | $ / shares 239.77
SARs, weighted average exercise price, ending balance (USD per share) | $ / shares 197.31
SARs, weighted average exercise price, vested and expected to vest (USD per share) | $ / shares 196.10
SARs, weighted average exercise price, exercisable (USD per share) | $ / shares $ 180.47
SARs, weighted average remaining contractual term 5 years 7 months 28 days
SARs, weighted average remaining contractual term, vested and expected to vest 5 years 6 months 29 days
SARs, weighted average remaining contractual term, exercisable 4 years 6 months 3 days
SARs, aggregate intrinsic value | $ $ 183
SARs, aggregate intrinsic value, vested and expected to vest | $ 183
SARs, aggregate intrinsic value, exercisable | $ $ 183